---
title: "AXSM SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Axsome Therapeutics (AXSM), with links to the SEC filings."
url: "https://tradytics.com/research/AXSM/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=AXSM&v=stock-11994868"
---

# AXSM financial statements and SEC filings

## AXSM annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $638.50M | -$166.76M | -$183.17M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2024-12-31 | $385.69M | -$280.56M | -$287.22M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2023-12-31 | $270.60M | -$231.82M | -$239.24M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2022-12-31 | $50.04M | -$179.80M | -$187.13M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017025022457/0000950170-25-022457-index.htm) |
| 2021-12-31 | – | -$124.71M | -$130.40M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017024019118/0000950170-24-019118-index.htm) |
| 2020-12-31 | – | -$99.14M | -$102.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017023004728/0000950170-23-004728-index.htm) |

## AXSM annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $689.80M | $601.51M | $88.30M | [10-Q](https://www.sec.gov/Archives/edgar/data/1579428/000119312526443752/0001193125-26-443752-index.htm) |
| 2024-12-31 | $568.50M | $511.48M | $57.02M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2023-12-31 | $588.24M | $397.26M | $190.98M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017025022457/0000950170-25-022457-index.htm) |
| 2022-12-31 | $331.48M | $221.92M | $109.56M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017024019118/0000950170-24-019118-index.htm) |
| 2021-12-31 | $87.79M | $72.15M | $15.63M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017023004728/0000950170-23-004728-index.htm) |
| 2020-12-31 | $186.13M | $72.34M | $113.79M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017022002568/0000950170-22-002568-index.htm) |

## AXSM annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$93.41M | -$480.00K | $101.47M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2024-12-31 | -$128.41M | -$270.00K | $57.84M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2023-12-31 | -$145.08M | -$582.00K | $331.01M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm) |
| 2022-12-31 | -$116.51M | -$702.00K | $284.58M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017025022457/0000950170-25-022457-index.htm) |
| 2021-12-31 | -$108.23M | -$308.00K | $11.13M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017024019118/0000950170-24-019118-index.htm) |
| 2020-12-31 | -$78.46M | -$45.89K | $42.41M | [10-K](https://www.sec.gov/Archives/edgar/data/1579428/000095017023004728/0000950170-23-004728-index.htm) |

- [AXSM stock research](https://tradytics.com/research/AXSM)
- [AXSM financial summary](https://tradytics.com/research/AXSM/financials)
- [Read the data without JavaScript](https://tradytics.com/research/AXSM/fundamentals?snapshot=1)
